loadpatents
name:-0.091590881347656
name:-0.063279867172241
name:-0.0098080635070801
Haupt; Andreas Patent Filings

Haupt; Andreas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Haupt; Andreas.The latest application filed is for "tricyclic quinoline and quinoxaline derivatives".

Company Profile
10.86.79
  • Haupt; Andreas - Ludwigshafen DE
  • Haupt; Andreas - Wiesbaden DE
  • Haupt; Andreas - Schwetzingen DE
  • Haupt; Andreas - Schweizingen N/A DE
  • - Schweizingen DE
  • Haupt; Andreas - Erfurt N/A DE
  • HAUPT; Andreas - Northborough MA US
  • Haupt; Andreas - Schwerzingen DE
  • Haupt; Andreas - Westborough MA
  • Haupt, Andreas - US
  • Haupt; Andreas - Gottingen DE
  • Haupt; Andreas - Oberursel DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tricyclic Quinoline And Quinoxaline Derivatives
App 20200283439 - Koolman; Hannes ;   et al.
2020-09-10
Proline Amide Compounds And Their Azetidine Analogues Carrying A Specifically Substituted Benzyl Radical
App 20200039930 - Backfisch; Gisela ;   et al.
2020-02-06
Hexahydropyrazinobenz- Or -pyrido-oxazepines Carrying An Oxygen-containing Substituent And Use Thereof In The Treatment Of 5-ht2
App 20200002354 - Backfisch; Gisela ;   et al.
2020-01-02
Quinoline Compounds Suitable For Treating Disorders That Respond To The Modulation Of The Serotonin 5-ht6 Receptor
App 20190135777 - GENESTE; Herve ;   et al.
2019-05-09
Tricyclic Quinoline And Quinoxaline Derivatives
App 20190071443 - Koolman; Hannes ;   et al.
2019-03-07
Pyridyl Or Pyrazinyl Compounds Carrying A Methyl-bound Alpha-amino Acid Amide Group
App 20190062305 - BACKFISCH; Gisela ;   et al.
2019-02-28
Tricyclic Quinoline And Quinoxaline Derivatives
App 20190048007 - Koolman; Hannes ;   et al.
2019-02-14
Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT.sub.6 receptor
Grant 10,160,744 - Geneste , et al. Dec
2018-12-25
Hexahydropyrazinobenz- Or -pyrido-oxazepines Carrying An Oxygen-containing Substituent And Use Thereof In The Treatment Of 5-ht2c-dependent Disorders
App 20180339996 - BACKFISCH; Gisela ;   et al.
2018-11-29
Tricyclic quinoline and quinoxaline derivatives
Grant 10,118,926 - Koolman , et al. November 6, 2
2018-11-06
Tricyclic quinoline and quinoxaline derivatives
Grant 9,994,568 - Koolman , et al. June 12, 2
2018-06-12
Quinoline Compounds Suitable For Treating Disorders That Respond To The Modulation Of The Serotonin 5-ht6 Receptor
App 20170260158 - GENESTE; Herve ;   et al.
2017-09-14
Hexahydrodiazepinoquinolines Carrying A Cyclic Radical
App 20170158693 - BACKFISCH; Gisela ;   et al.
2017-06-08
Hexahydrodiazepinoquinolines Carrying A Substituted Alkyl Radical
App 20170112851 - BACKFISCH; Gisela ;   et al.
2017-04-27
Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators
Grant 9,573,950 - Backfisch , et al. February 21, 2
2017-02-21
Hexahydrodiazepinoquinolines carrying a substituted alkyl radical
Grant 9,540,376 - Backfisch , et al. January 10, 2
2017-01-10
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
Grant 9,388,148 - Haupt , et al. July 12, 2
2016-07-12
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
Grant 9,388,141 - Haupt , et al. July 12, 2
2016-07-12
Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
Grant 9,376,396 - Haupt , et al. June 28, 2
2016-06-28
Tricyclic Quinoline And Quinoxaline Derivatives
App 20160016954 - Koolman; Hannes ;   et al.
2016-01-21
Tricyclic quinoline and quinoxaline derivatives
Grant 9,169,253 - Koolman , et al. October 27, 2
2015-10-27
Hexahydrodiazepinoquinolines Carrying A Cyclic Radical
App 20150259343 - BACKFISCH; Gisela ;   et al.
2015-09-17
Hexahydrodiazepinoquinolines Carrying A Substituted Alkyl Radical
App 20150259346 - BACKFISCH; Gisela ;   et al.
2015-09-17
5-ring Heteroaromatic Compounds And Their Use As Binding Partners For 5-ht5 Receptors
App 20150183770 - Amberg; Wilhelm ;   et al.
2015-07-02
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20150175570 - Turner; Sean Colm ;   et al.
2015-06-25
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 8,969,552 - Drescher , et al. March 3, 2
2015-03-03
5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors
Grant 8,921,406 - Amberg , et al. December 30, 2
2014-12-30
5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors
Grant 08921406 -
2014-12-30
Acylaminocycloalkyl Compounds Suitable For Treating Disorders That Respond To Modulation Of Dopamine D3 Receptor
App 20140303176 - HAUPT; Andreas ;   et al.
2014-10-09
Acylaminocycloalkyl Compounds Suitable For Treating Disorders That Respond To Modulation Of Dopamine D3 Receptor
App 20140275104 - HAUPT; Andreas ;   et al.
2014-09-18
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20140200224 - Turner; Sean Colm ;   et al.
2014-07-17
Acylaminocycloalkyl Compounds Suitable For Treating Disorders That Respond To Modulation Of Dopamine D3 Receptor
App 20140194437 - Haupt; Andreas
2014-07-10
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT.sub.6 receptor
Grant 8,772,313 - Haupt , et al. July 8, 2
2014-07-08
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT.sub.6 receptor
Grant 8,710,059 - Haupt , et al. April 29, 2
2014-04-29
Tricyclic Quinoline And Quinoxaline Derivatives
App 20140080816 - Koolman; Hannes ;   et al.
2014-03-20
Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
Grant 8,642,642 - Grandel , et al. February 4, 2
2014-02-04
Device and method for providing a television sequence using database and user inputs
Grant 8,566,880 - Dunker , et al. October 22, 2
2013-10-22
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT.sub.6 receptor
Grant 8,507,469 - Schultz , et al. August 13, 2
2013-08-13
Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
Grant 8,497,273 - Grandel , et al. July 30, 2
2013-07-30
1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 8,492,540 - Braje , et al. July 23, 2
2013-07-23
Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 8,486,984 - Drescher , et al. July 16, 2
2013-07-16
N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor
Grant 8,476,275 - Braje , et al. July 2, 2
2013-07-02
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 8,470,810 - Drescher , et al. June 25, 2
2013-06-25
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT.sub.6 receptor
Grant 8,440,694 - Turner , et al. May 14, 2
2013-05-14
Antineoplastic peptides
Grant 8,440,626 - Amberg , et al. May 14, 2
2013-05-14
Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 8,383,641 - Grandel , et al. February 26, 2
2013-02-26
Dolastatin 15 Derivatives
App 20130046077 - JANSSEN; Bernd ;   et al.
2013-02-21
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT.sub.6 receptor
Grant 8,362,010 - Haupt , et al. January 29, 2
2013-01-29
N-phenyl-(piperazinyl Or Homopiperazinyl)-benzenesulfonamide Or Benzenesulfonyl-phenyl-(piperazine Or Homopiperazine) Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20130018047 - Haupt; Andreas ;   et al.
2013-01-17
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
Grant 8,343,959 - Haupt , et al. January 1, 2
2013-01-01
Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor
Grant 8,334,289 - Geneste , et al. December 18, 2
2012-12-18
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT.sub.6 receptor
Grant 8,293,913 - Turner , et al. October 23, 2
2012-10-23
Pyrimidine compounds and use thereof
Grant 8,268,815 - Geneste , et al. September 18, 2
2012-09-18
Aminoethylaromatic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20120220635 - Drescher; Karla ;   et al.
2012-08-30
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
Grant 8,242,102 - Turner , et al. August 14, 2
2012-08-14
Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 8,232,426 - Drescher , et al. July 31, 2
2012-07-31
Tetrahydrobenzazepines and their use in he modulation of the dopamine D.sub.3 receptor
Grant 8,207,160 - Braje , et al. June 26, 2
2012-06-26
4-piperazinyl-pyrimidine compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 8,202,868 - Haupt , et al. June 19, 2
2012-06-19
N-phenyl-(homo)piperazinyl-benzenesulfonyl Or Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To The Modulation Of The Serotonin 5-ht6 Receptor
App 20120142674 - Haupt; Andreas ;   et al.
2012-06-07
Benzenesulfonyl Or Sulfonamide Compounds Suitable For Treating Disorders That Respond To The Modulation Ofthe Serotonin 5-ht6 Receptor
App 20120129883 - Haupt; Andreas ;   et al.
2012-05-24
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT.sub.6 receptor
Grant 8,183,237 - Haupt , et al. May 22, 2
2012-05-22
Dolastatin 15 derivatives
Grant 8,163,698 - Janssen , et al. April 24, 2
2012-04-24
Triazole Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20120095015 - Unger; Liliane ;   et al.
2012-04-19
N-phenyl-(piperazinyl Or Homopiperazinyl)-benzenesulfonamide Or Benzenesulfonyl-phenyl-(piperazine Or Homopiperazine) Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20120040969 - Haupt; Andreas ;   et al.
2012-02-16
Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 8,101,754 - Unger , et al. January 24, 2
2012-01-24
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20110319421 - Turner; Sean Colm ;   et al.
2011-12-29
N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT.sub.6 receptor
Grant 8,076,326 - Haupt , et al. December 13, 2
2011-12-13
N-[piperazinyl Hetaryl]arylsufonamide Compounds With Affinity For The Dopamine D3 Receptor
App 20110294817 - Braje; Wilfried ;   et al.
2011-12-01
Pyridin-2-one Compounds And Their Use As Modulators Of The Dopamine D3 Receptor
App 20110245266 - Geneste; Herve ;   et al.
2011-10-06
Pyrimidin-2-one compounds and their use as dopamine D.sub.3 receptor ligands
Grant 8,008,488 - Geneste , et al. August 30, 2
2011-08-30
5-Ring Heteroaromatic compounds and their use as binding partners for 5-ht5 receptors
App 20110207788 - Amberg; Wilhelm ;   et al.
2011-08-25
Device and Method for Providing a Television Sequence
App 20110179452 - Dunker; Peter ;   et al.
2011-07-21
Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20110160176 - Drescher; Karla ;   et al.
2011-06-30
Aminomethyl Substituted Bicyclic Aromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
App 20110144146 - Drescher; Karla ;   et al.
2011-06-16
Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor
Grant 7,960,386 - Geneste , et al. June 14, 2
2011-06-14
Pyrimidine Compounds And Use Thereof
App 20110118232 - Geneste; Herve ;   et al.
2011-05-19
Antineoplastic Peptides
App 20110098235 - AMBERG; Wilhelm ;   et al.
2011-04-28
Benzenesulfonanilide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20110086863 - Braje; Wilfried Martin ;   et al.
2011-04-14
Quinoline Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20110009380 - Turner; Sean Colm ;   et al.
2011-01-13
Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 7,851,463 - Drescher , et al. December 14, 2
2010-12-14
1,2,4,-triazin-3,5-dione Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20100311755 - Braje; Wilfried ;   et al.
2010-12-09
Quinoline Compounds Suitable for Treating Disorders that Respond to Modulation of the Serotonin-5-HT6 Receptor
App 20100292271 - Turner; Sean Colm ;   et al.
2010-11-18
Benzenesulfonanilide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20100292221 - Haupt; Andreas ;   et al.
2010-11-18
Benzenesulfonanilide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20100292220 - Haupt; Andreas ;   et al.
2010-11-18
Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 7,834,048 - Drescher , et al. November 16, 2
2010-11-16
N-phenyl- (piperazinyl Or Homopiperazinyl)-benzenesulfonamide Or Benzenesulfonyl-phenl-(piperazine Or Homopiperazine) Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20100280014 - Haupt; Andreas ;   et al.
2010-11-04
Antineoplastic peptides
Grant 7,807,779 - Amberg , et al. October 5, 2
2010-10-05
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
Grant 7,790,727 - Braje , et al. September 7, 2
2010-09-07
Pyrimidine compounds and use thereof
Grant 7,786,105 - Geneste , et al. August 31, 2
2010-08-31
Benzenesulfonamide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20100210664 - Turner; Sean Colm ;   et al.
2010-08-19
6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D.sub.3 receptor
Grant 7,759,397 - Drescher , et al. July 20, 2
2010-07-20
Azetidin Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20100137280 - Schultz, SR.; Thomas ;   et al.
2010-06-03
Keto lactam compounds and use thereof
Grant 7,723,384 - Lubisch , et al. May 25, 2
2010-05-25
Dolastatin 15 Derivatives
App 20100099843 - JANSSEN; Bernd ;   et al.
2010-04-22
Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5ht6 Receptor
App 20100048582 - Grandel; Roland ;   et al.
2010-02-25
Dolastatin 15 derivatives
Grant 7,662,786 - Janssen , et al. February 16, 2
2010-02-16
Heterocyclic Arylsulphones Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5ht6 Receptor
App 20090306175 - Grandel; Roland ;   et al.
2009-12-10
4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
App 20090264437 - Haupt; Andreas ;   et al.
2009-10-22
Aryloxyethylamine Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20090143383 - Grandel; Roland ;   et al.
2009-06-04
Benzenesulfonanilide Compounds Suitable For Treating Disorders That Respond To Modulation Of The Serotonin 5-ht6 Receptor
App 20090131452 - Braje; Wilfried Martin ;   et al.
2009-05-21
Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
App 20090105224 - Braje; Wilfried ;   et al.
2009-04-23
Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
App 20090048326 - Drescher; Karla ;   et al.
2009-02-19
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the Dopamine D3 receptor
App 20090012074 - Drescher; Karla ;   et al.
2009-01-08
6-Amino(Aza)Indane Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
App 20080318996 - Drescher; Karla ;   et al.
2008-12-25
Triazole compounds and the therapeutic use thereof
Grant 7,465,744 - Starck , et al. December 16, 2
2008-12-16
Pyridin-2-One Compounds and Their Use as Modulators of the Dopamine D3 Receptor
App 20080261992 - Geneste; Herve ;   et al.
2008-10-23
Antineoplastic peptides
App 20080234205 - Amberg; Wilhelm ;   et al.
2008-09-25
Triazole Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
App 20080171751 - Unger; Liliane ;   et al.
2008-07-17
Pyrimidine Compounds and Use Thereof
App 20080161322 - Geneste; Herve ;   et al.
2008-07-03
Antineoplastic peptides
Grant 7,368,528 - Amberg , et al. May 6, 2
2008-05-06
Aminoethylaromatic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20080096934 - Drescher; Karla ;   et al.
2008-04-24
Heterocyclic Compounds Suitable For Treating Disorders That Respond To Modulation Of The Dopamine D3 Receptor
App 20080045493 - Drescher; Karla ;   et al.
2008-02-21
N-[(piperazinyl)hetaryl]arylsulfonamide compounds
Grant 7,320,979 - Braje , et al. January 22, 2
2008-01-22
Keto Lactam Compounds and Use Thereof
App 20070219182 - Lubisch; Wilfried ;   et al.
2007-09-20
N-[(piperazinyl)hetary]arylsulfonamide compounds with affinity for the dopamine d3 receptor
App 20070054918 - Braje; Wilfried ;   et al.
2007-03-08
Dolastatin 15 derivatives
App 20060270606 - Janssen; Bernd ;   et al.
2006-11-30
Triazole compounds and the therapeutic use thereof
App 20060241137 - Starck; Dorothea ;   et al.
2006-10-26
Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
App 20060235004 - Geneste; Herve ;   et al.
2006-10-19
Dolastatin 15 derivatives
Grant 7,084,110 - Janssen , et al. August 1, 2
2006-08-01
N-[(piperazinyl)hetaryl]arylsulfonamide compounds
App 20060160809 - Braje; Wilfried M. ;   et al.
2006-07-20
Antineoplastic peptides
App 20060009392 - Amberg; Wilhelm ;   et al.
2006-01-12
Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Grant 6,919,342 - Haupt , et al. July 19, 2
2005-07-19
Tetrahydrobenzazepines and their use
App 20050137186 - Braje, Wilfried M. ;   et al.
2005-06-23
Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
App 20040259882 - Haupt, Andreas ;   et al.
2004-12-23
N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
App 20040204422 - Braje, Wilfried M. ;   et al.
2004-10-14
Low molecular weight inhibitors of complement proteases
Grant 6,683,055 - Hillen , et al. January 27, 2
2004-01-27
Dolastatin-15 derivatives in combination with taxanes
Grant 6,632,795 - Barlozzari , et al. October 14, 2
2003-10-14
Dolastatin 15 derivatives
App 20030153505 - Janssen, Bernd ;   et al.
2003-08-14
Method of identifying inhibitors of CDC25
App 20020183249 - Taylor, Neil R. ;   et al.
2002-12-05
Dolastatin 15 derivatives
Grant 6,458,765 - Janssen , et al. October 1, 2
2002-10-01
Apparatus for purging the beam path of a UV laser beam
Grant 6,399,916 - Gortler , et al. June 4, 2
2002-06-04
Dolastatin peptides
Grant 6,323,315 - Pettit , et al. November 27, 2
2001-11-27
Dolastatin 15 derivatives
App 20010018422 - Ritter, Kurt ;   et al.
2001-08-30
Antineoplastic peptides
App 20010009901 - Amberg, Wilhelm ;   et al.
2001-07-26
Compounds useful for the synthesis of dolastatin analogs
Grant 6,248,865 - Amberg , et al. June 19, 2
2001-06-19
Device for flushing the optical path of a UV laser beam
App 20010000606 - Gortler, Andreas ;   et al.
2001-05-03
Dolastatin 15 derivatives
Grant 6,143,721 - Janssen , et al. November 7, 2
2000-11-07
Dolastatin-15 derivatives in combination with taxanes
Grant 6,103,698 - Barlozzari , et al. August 15, 2
2000-08-15
Methods and compositions for treating rheumatoid arthritis
Grant 6,015,790 - Barlozzari , et al. January 18, 2
2000-01-18
Dolastatin 15 derivatives
Grant 5,985,837 - Ritter , et al. November 16, 1
1999-11-16
Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
Grant 5,965,537 - Ritter , et al. October 12, 1
1999-10-12
Preparation of active peptides
Grant 5,965,700 - Amberg , et al. October 12, 1
1999-10-12
Tetrapeptides as antitumor agents
Grant 5,939,527 - Barlozzari , et al. August 17, 1
1999-08-17
Antitumor peptides
Grant 5,831,002 - Haupt , et al. November 3, 1
1998-11-03
Oligopeptides, the preparation and use thereof
Grant 5,807,984 - Kling , et al. September 15, 1
1998-09-15
Pentapeptides as antitumor agents
Grant 5,741,892 - Barlozzari , et al. April 21, 1
1998-04-21
Peptides, their preparation and use
Grant 5,504,189 - Emling , et al. April 2, 1
1996-04-02
Peptides, the preparation and use thereof
Grant 5,502,032 - Haupt , et al. March 26, 1
1996-03-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed